Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 36 - Advisory Commission on Childhood Vaccines - Statutory (Congress Created)


Committee NameAdvisory Commission on Childhood VaccinesAgency NameDepartment of Health and Human Services
Fiscal Year2021Committee Number36
Original Establishment Date10/1/1988Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*13
Current Charter Date7/21/2020Designated Fed Officer Position Title*Acting Director, Division of Injury Compensation Programs
Date Of Renewal Charter7/21/2022Designated Federal Officer PrefixMs.
Projected Termination Date Designated Federal Officer First Name*Tamara
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Overby
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixMBA
Specific Establishment Authority*42 U.S.C. 300aa-19Designated Federal Officer Phone*(301) 443-3766
Effective Date Of Authority*10/1/1988Designated Federal Officer Fax*(301) 443-0704
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*National Policy Issue Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Advisory Commission on Childhood Vaccines (ACCV) accomplishes its purpose by meeting in full session and establishing special topic workgroups. In Fiscal Year (FY) 2021, the ACCV continued to meet and have discussions on topics regarding the National Vaccine Injury Compensation Program (VICP). Each meeting included representatives from various federal government agencies, as well as other stakeholders (i.e. vaccine manufacturer, petitioner’s attorney).
How is membership balanced?*The ACCV members consist of three health professionals who are not employees of the federal government, and who have expertise in the health care of children, the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines, of whom at least two are pediatricians; three members from the general public, of whom at least two shall be legal representatives of children who have suffered a vaccine-related injury or death; and three attorneys, of whom at least one is an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death and one who is an attorney whose specialty includes representation of vaccine manufacturers.
How frequent & relevant are cmte mtgs?*The ACCV meets four times a year to advise the Secretary of HHS on matters related to the implementation of the VICP. However, due to June 18th being designated a federal holiday, the ACCV only met three times in FY 2021.
Why advice can't be obtained elsewhere?*The ACCV members represent the various stakeholders that have an interest in the VICP, and provide scientific, legal and practical advice and recommendations to the Secretary of HHS. This expertise is not available within HHS.
Why close or partially close meetings?N/A
Recommendation RemarksNo Reports for FY 2021. Member Barbara Pahud's term end date changed from 1/1/2023 due to this member resigning from the ACCV in July 2021. Patricia Woodi's term end date changed from 8/30/2022 due to this ex-officio being replaced by Jonathan Duffy at CDC in FY 2021. ACCV had no Chair for FY 2021; only a Vice-Chair, Karen Kain. ACCV member William Spiegel was erroneously missing in the FY 2020 ACR. Their appointment term is 05/10/2020
thru 05/10/2023.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationYes
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentIn FY 2021, the ACCV recommended that the Secretary support efforts to increase the number of Special Masters and the amount of staffing and funding resources for the VICP. This recommendation was included in a letter sent to the Secretary on December 2, 2020. All ACCV recommendations are posted on the ACCV website at
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Under $100,000Dollar Value Of Grants Recommended$0.00
Cost Savings CommentDue to COVID outbreak the ACCV held all of the meetings virtually. Therefore no travel reimbursements were made in FY 21.Grants Review CommentNA
Number Of Recommendations*63Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThese recommendations provide advice to the Secretary of HHS regarding the VICP.Access Agency WebsiteYes
% of Recs Fully Implemented*44.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThese recommendations have been implemented to improve aspects of the VICP. No new recommendations were made in FY 21 but recommendations made in previous years were implemented.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*5.00%Access PublicationsNo
% of Recs Partially Implemented CommentThese recommendations have been implemented to improve aspects of the VICP.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*The Secretary of HHS acknowledges receipt of the ACCV recommendations, and thanks the ACCV for providing advice and recommendations on the VICP. The public can obtain information on agency feedback at the ACCV website: Description*The ACCV provides advice and makes recommendations to the Secretary of HHS regarding the VICP.
Hide Section - COSTS


Payments to Non-Federal Members*$7,176.00Est Payments to Non-Fed Members Next FY*$19,136.00
Payments to Federal Members*$22,691.00Est. Payments to Fed Members Next FY*$22,495.00
Payments to Federal Staff*$257,295.00Estimated Payments to Federal Staff*$266,016.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$12,000.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$3,600.00Est. Other Costs Next FY*$3,650.00
Total Costs$290,762.00Est. Total Next FY*$323,297.00
Date Cost Last Modified12/15/2021 7:30 AMEst. Fed Staff Support Next FY*1.50
Federal Staff Support (FTE)*1.50Est Cost RemarksEst Payments to Non-Fed Members - During FY 21 the ACCV only had a max of 5 members and only met 3 times. This cost is increased due to the estimated number of members we hope to have (8) times the number of meeting days (4).

Est Travel Reimb for Non-Fed - Travel is estimated at $12,000 assuming we will be allowed to hold two in-person meetings later in the year.

Est Other Costs - This cost covers payment to a contractor for the meeting minutes and other meeting supplies. Assuming we can have two in-person meetings this would cover notebooks and meeting handouts.
Cost RemarksThere is a difference in payments to federal staff from the current charter than what is stated above because the charter reflects budget factors from FY 2019 and since that date staffing changes have been implemented.  
Hide Section - Interest Areas

Interest Areas

Civil Rights
Food and Drugs
Food and Drugs
Health and Health Research
Medicine and Dentistry


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-038612Advisory Commission on Childhood Vaccines2020
 COM-036484Advisory Commission on Childhood Vaccines2019
 COM-034684Advisory Commission on Childhood Vaccines2018
 COM-001728Advisory Commission on Childhood Vaccines2017
 COM-002350Advisory Commission on Childhood Vaccines2016
 COM-004015Advisory Commission on Childhood Vaccines2015
 COM-004442Advisory Commission on Childhood Vaccines2014
 COM-005898Advisory Commission on Childhood Vaccines2013
 COM-006477Advisory Commission on Childhood Vaccines2012
 COM-008045Advisory Commission on Childhood Vaccines2011
 COM-008689Advisory Commission on Childhood Vaccines2010
 COM-010267Advisory Commission on Childhood Vaccines2009
 COM-010662Advisory Commission on Childhood Vaccines2008
 COM-012248Advisory Commission on Childhood Vaccines2007
 COM-012867Advisory Commission on Childhood Vaccines2006
 COM-013983Advisory Commission on Childhood Vaccines2005
 COM-014569Advisory Commission on Childhood Vaccines2004
 COM-015644Advisory Commission on Childhood Vaccines2003
 COM-016782Advisory Commission on Childhood Vaccines2002
 COM-017776Advisory Commission on Childhood Vaccines2001
 COM-018389Advisory Commission on Childhood Vaccines2000
 COM-019539Advisory Commission on Childhood Vaccines1999
 COM-020543Advisory Commission on Childhood Vaccines1998
 COM-021627Advisory Commission on Childhood Vaccines1997